Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsMona Shahriari, MD
Associate Clinical ProfessorAbout
Research
Publications
2026
Long-term Upadacitinib Safety in Moderate-to-Severe Atopic Dermatitis up to 7 Years: an Integrated Analysis with Over 9600 Patient-Years of exposure
Guttman E, Levy G, Ruiz DaSilva D, Shahriari M, Stein Gold L, Magnolo N, Masuda K, Nosbaum A, Foley P, Wiseman M, Grada A, Armendariz Y, Dilley D, Pechonkina A, Bunick C. Long-term Upadacitinib Safety in Moderate-to-Severe Atopic Dermatitis up to 7 Years: an Integrated Analysis with Over 9600 Patient-Years of exposure. SKIN The Journal Of Cutaneous Medicine 2026, 10: s727. DOI: 10.25251/evafb145.Peer-Reviewed Original ResearchTreatment-emergent adverse eventsPatient years of exposureModerate-to-severe ADPatient yearsBenefit-risk profileAtopic dermatitisAdverse eventsPlacebo-ControlledRates of treatment-emergent adverse eventsModerate-to-severe atopic dermatitisEffective long-term treatment optionLow rate of adverse eventsLong-term treatment optionChronic inflammatory skin diseaseIncidence rateRate of adverse eventsVenous thromboembolic eventsExposure-adjusted ratesNonmelanoma skin cancerPhase 3 trialInflammatory skin diseaseJanus kinase inhibitorsUpadacitinib treatmentOral monotherapySerious AERapid and Durable Skin Pain Relief with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
Bunick C, Lio P, Shahriari M, Ruiz Dasilva D, Grada A, Calimlim B, Prefontaine D, Li C, Zhang J, Jain V, Mendes-Bastos P, Simpson E. Rapid and Durable Skin Pain Relief with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal Of Cutaneous Medicine 2026, 10: s741. DOI: 10.25251/mwffsw72.Peer-Reviewed Original ResearchPatient-reported outcomesSkin painNon-responder imputationNumerical rating scaleAtopic dermatitisDouble-blindQuality of lifeResponse rateOral selective Janus kinase 1 inhibitorLong-term maintenance of responseModerate-to-severe atopic dermatitisFeatures of atopic dermatitisJanus kinase 1 inhibitorPain numerical rating scaleLong-term extension periodSkin Pain Numeric Rating ScaleEfficacy of upadacitinibUPA-treated patientsModerate-to-severe ADPlacebo-controlled periodLong-term maintenanceMaintenance of responsePlacebo groupAssociated with improvementsPain reliefHead and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab
Ruiz Dasilva D, Shahriari M, Abe M, Torres T, Ribero S, Yu H, Miller L, Altman K, Lane M, Moreira A, Grada A, Bunick C. Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab. SKIN The Journal Of Cutaneous Medicine 2026, 10: s740. DOI: 10.25251/ztj3rn69.Peer-Reviewed Original ResearchModerate-to-severe ADOpen-label extensionHead and neckClinical responseInadequate respondersEASI scoreAtopic dermatitisResponse to dupilumabAtopic dermatitis patientsClinically Meaningful ImprovementsEffective therapeutic strategyEczema AreaTherapeutic responseDupilumabMonth 1HN lesionsDermatitis patientsPatient populationUpadacitinibWeek 4Therapeutic strategiesEASI75Therapeutic gapMeaningful improvementsPatientsGradation of Prolonged Venous Transit on Perfusion Imaging Highlights the Association of Deep Venous Drainage Impairment with Unfavorable Functional Outcome in Successfully Reperfused Anterior Circulation Large-Vessel-Occlusion Stroke.
Mei J, Salim H, Lakhani D, Balar A, Shahriari M, Liebeskind D, Sriwastwa A, Guenego A, Dmytriw A, Urrutia V, Marsh E, Lu H, Xu R, Leigh R, Wolman D, Shah G, Pulli B, Albers G, Hillis A, Llinas R, Nael K, Wintermark M, Heit J, Faizy T, Yedavalli V. Gradation of Prolonged Venous Transit on Perfusion Imaging Highlights the Association of Deep Venous Drainage Impairment with Unfavorable Functional Outcome in Successfully Reperfused Anterior Circulation Large-Vessel-Occlusion Stroke. American Journal Of Neuroradiology 2026, 47: 604-610. PMID: 41781176, PMCID: PMC12964433, DOI: 10.3174/ajnr.a9074.Peer-Reviewed Original ResearchConceptsSuperior sagittal sinusPosterior superior sagittal sinusAIS-LVOFunctional outcomesMRS scoreFavorable outcomeAnterior circulation large-vessel occlusion strokeAssociated with worse outcomesNegative prognostic impactUnfavorable functional outcomeProportion of patientsModified TICI scoreOdds of favorable outcomeLarge-vessel occlusion strokeAdmission NIHSS scoreMultivariate logistic regressionLarge-vessel occlusionAcute ischemic strokeBaseline CTPPVT groupPrognostic impactProspective registryDrainage dysfunctionTICI scoreHemorrhagic transformationOutcomes in Bimekizumab Treated Psoriasis Patients With Prior IL-17 Inhibitor Failure.
Song E, Pretorius P, Dasilva D, Bunick C, Liu C, Shahriari M. Outcomes in Bimekizumab Treated Psoriasis Patients With Prior IL-17 Inhibitor Failure. Journal Of Psoriasis And Psoriatic Arthritis 2026, 24755303251412379. PMID: 41523710, PMCID: PMC12783026, DOI: 10.1177/24755303251412379.Peer-Reviewed Original ResearchIntra-class switchIL-17Non-respondersIL-17 inhibitor therapyModerate-to-severe psoriasisIL-17 inhibitorsSecondary non-respondersIL-17 therapyLack of efficacyTreating psoriasis patientsReal-world studyPsoriasis therapeuticsTreatment intoleranceInhibitor therapyPsoriasis patientsBimekizumabClass switchingRetrospective dataPatientsInhibitor classBiologic discontinuationTherapyPsoriasisIgAIxekizumab
2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
Bunick C, Irvine A, Silverberg J, GuttmanâYassky E, Shahriari M, Gao X, Weidinger S, Katoh N, Vigna N, Dilley D, D'Andrea E, Teixeira H, Platt A, Levy G. Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years. Journal Of The European Academy Of Dermatology And Venereology 2025 PMID: 41239921, DOI: 10.1111/jdv.70172.Peer-Reviewed Original ResearchTreatment-emergent adverse eventsModerate-to-severe ADSafety of upadacitinibAdverse eventsLong-term safetyAtopic dermatitisEvent incidence ratesRates of treatment-emergent adverse eventsGlobal phase 3 studyOnce-daily oral treatmentLong-term safety profileNon-melanoma skin cancerIncidence rateSerious adverse event ratesRate of lymphomaPhase 3 studyRate of malignancyEvent ratesAdverse event ratesInflammatory skin diseaseRandomized clinical trialsSerious infectionHerpes zosterEczematous lesionsSafety profileUnmet Needs and Disease Burden: Perspectives from Adults with Psoriasis and Clinicians Treating Psoriasis in the US
Stein Gold L, Soung J, Trenkler N, Taylor M, Conklin L, Lewis J, Fitzgerald T, Peters W, Yang Y, Li G, Shahriari M. Unmet Needs and Disease Burden: Perspectives from Adults with Psoriasis and Clinicians Treating Psoriasis in the US. SKIN The Journal Of Cutaneous Medicine 2025, 9: s644. DOI: 10.25251/nkn06k92.Peer-Reviewed Original ResearchProlonged venous transit and clinical outcomes in anterior circulation large-vessel occlusion stroke with complete or near-complete reperfusion
Salim H, Lakhani D, Balar A, Mei J, Luna L, Shahriari M, Hyson N, Deng F, Dmytriw A, Guenego A, Urrutia V, Marsh E, Lu H, Xu R, Leigh R, Shah G, Wen S, Albers G, Hillis A, Llinas R, Nael K, Wintermark M, Heit J, Faizy T, Yedavalli V. Prolonged venous transit and clinical outcomes in anterior circulation large-vessel occlusion stroke with complete or near-complete reperfusion. Neuroradiology 2025, 67: 3173-3184. PMID: 41182415, DOI: 10.1007/s00234-025-03799-4.Peer-Reviewed Original ResearchConceptsAIS-LVO patientsAIS-LVOMechanical thrombectomyPrognostic significanceAnterior circulation large-vessel occlusion strokeModified Rankin Scale (mRSPosterior superior sagittal sinusNegative prognostic markerAnterior circulation occlusionHigh-risk patientsNear-complete reperfusionNIH Stroke Scale scoreSuperior sagittal sinusImpaired venous outflowLarge-vessel occlusion strokeStroke Scale scoreLarge-vessel occlusionAcute ischemic strokeExcellent reperfusionMTICI 2cMethodsRetrospective analysisCT perfusionProspective registryPrognostic markerBaseline characteristicsProlonged Venous Transit Is Associated with Unfavorable Functional Outcomes in Large-Core Stroke.
Salim H, Lakhani D, Mei J, Dmytriw A, Balar A, Shahriari M, Liebeskind D, Guenego A, Vagal V, Hoseinyazdi M, Marsh E, Lu H, Xu R, Leigh R, Wolman D, Shah G, Pulli B, Albers G, Hillis A, Llinas R, Nael K, Wintermark M, Heit J, Faizy T, Yedavalli V. Prolonged Venous Transit Is Associated with Unfavorable Functional Outcomes in Large-Core Stroke. American Journal Of Neuroradiology 2025, 47: 596-603. PMID: 41102010, PMCID: PMC12964479, DOI: 10.3174/ajnr.a9047.Peer-Reviewed Original ResearchConceptsAssociated with unfavorable functional outcomeAssociated with unfavorable outcomesUnfavorable functional outcomeLarge-vessel occlusionAIS-LVOAcute ischemic strokeFunctional outcomesUnfavorable outcomeIschemic strokeIschemic core volumeImpaired venous drainageRetrospective cohort studySuperior sagittal sinusAssociated with higher ratesHigh-risk populationConsecutive patientsPrognostic markerPrognostic indicatorMRS scoreProspective studyVenous drainageSagittal sinusCohort studyAdmission NIHSSMultivariate analysisProlonged Venous Transit Is Associated With Unfavorable Outcomes in Anterior Circulation Distal Medium Vessel Stroke
Salim H, Lakhani D, Balar A, Shahriari M, Sriwastawa A, Cho A, Dmytriw A, Guenego A, Marsh E, Lu H, Xu R, Leigh R, Shah G, Wen S, Albers G, Hillis A, Llinas R, Nael K, Wintermark M, Heit J, Faizy T, Yedavalli V. Prolonged Venous Transit Is Associated With Unfavorable Outcomes in Anterior Circulation Distal Medium Vessel Stroke. Journal Of Neuroimaging 2025, 35: e70091. PMID: 40977128, PMCID: PMC12451256, DOI: 10.1111/jon.70091.Peer-Reviewed Original ResearchConceptsDistal medium vessel occlusionCerebral arteryAssociated with unfavorable functional outcomeMedian admission National Institutes of Health Stroke Scale scoreAssociated with unfavorable outcomesPosterior superior sagittal sinusAssociated with worse outcomesAdmission National Institutes of Health Stroke Scale scoreNational Institutes of Health Stroke Scale scoreUnfavorable functional outcomeAcute ischemic stroke casesRate of hemorrhagic transformationSuperior sagittal sinusAnterior cerebral arteryLarge-vessel occlusion strokeIschemic stroke casesMiddle cerebral arteryStroke Scale scoreMedium vessel occlusionsPoor venous outflowConsecutive patientsMRS 0Baseline characteristicsPrognostic indicatorRetrospective study